Skip to main content

Table 2 Major imaging features and LI-RADS categories for proliferative and non-proliferative HCC

From: Three-dimensional multifrequency magnetic resonance elastography improves preoperative assessment of proliferative hepatocellular carcinoma

 

Proliferative HCC

(n = 63)

Non-proliferative HCC (n = 61)

p value

Rim APHE

  

0.02*

 Absent

51 (80.95%)

58 (95.08%)

 

 Present

12 (19.05%)

3 (4.92%)

 

Nonperipheral washout

  

0.89

 Absent

24 (38.10%)

24 (39.34%)

 

 Present

39 (61.90%)

37 (60.66%)

 

Capsule

  

0.24

 Absent

26 (41.27%)

19 (31.15%)

 

 Present

37 (58.73%)

42 (68.85%)

 

Peritumoral enhancement

  

0.27

 Absent

56 (88.89%)

50 (81.97%)

 

 Present

7 (11.11%)

11 (18.03%)

 

Tumor margin

  

0.09

 Smooth

33 (52.38%)

41 (67.21%)

 

 Non-smooth

30 (47.62%)

20 (32.79%)

 

LR-RADS categorization

  

0.005*

 LR-M

12 (19.05%)

3 (4.92%)

 

 LR-TIV

4 (6.35%)

1 (1.64%)

 

 LR-3

7 (11.11%)

2 (3.28%)

 

 LR-4

13 (20.63%)

10 (16.39%)

 

 LR-5

27 (42.86%)

45 (73.77%)

 
  1. APHE arterial-phase hyperenhancement; LI-RADS Liver Imaging Reporting & Data System; TIV tumor in vein
  2. *Indicates statistically significant p values